Andrew Saintsing, PhD
Andrew was an intern at Drug Discovery News in 2023. He earned his PhD from the University of California, Berkeley in 2022 and has written for Integrative and Comparative Biology and the Journal of Experimental Biology. As an intern at DDN, he wrote about everything from microbes in the digestive tract to anatomical structures in the inner ear. When not writing, Andrew enjoys running and hiking in nature.
Articles by Andrew Saintsing, PhD
| 4 min read
Scientists probed how tick proteins influenced host immunity, paving the way for mRNA vaccines to block Lyme and other tick-borne diseases.
| 4 min read
Placental extracellular vesicles from maternal blood plasma identified women who would go on to develop complications later in their pregnancy.
| 3 min read
Immune cells carried an antioxidant to a mouse’s cardiac muscle cells, which had been damaged by a heart attack.
| 3 min read
Tamoxifen and a Mediterranean diet promoted bacterial communities that suppress breast tumor growth.
| 4 min read
People and mice with ALS-linked mutations show altered sleep patterns early in life. Modifying sleep hormone levels normalized sleep cycles in mice.
| 4 min read
The protein APLP1 strongly associates with brain-derived EVs. A blood test could one day isolate these molecular packets to diagnose neurological disorders.
| 4 min read
N-cadherins in smooth muscle cells play an important role in constricting bronchi, but inhibiting the protein could provide relief to patients with asthma.
| 5 min read
A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility.
| 4 min read
Mesenchymal stem cells form nanotubes with and donate mitochondria to T cells, boosting the immune cells’ cancer fighting abilities.
| 6 min read
A liver enzyme affects fibrosis progression by altering metabolism of the sugar trehalose in the gut.
| 5 min read
A new method for tracking CAR T cells in patients with blood cancers relies on a probe that binds directly to the therapeutic cells’ antigen receptor.
| 5 min read
The enzyme PGK1 sets the rate of cellular energy production and may be an ideal drug target when Parkinson’s disease neurons struggle to fuel themselves.
| 4 min read
Injecting lung stem cells into the bloodstream of mice with idiopathic pulmonary fibrosis improved their lung function, setting the stage for human trials.
| 9 min read
Ketamine effectively treats depression, but recent studies illustrate the ongoing difficulties in understanding its antidepressant effects at a molecular level.
| 9 min read
A new app relies on smartphone cameras and algorithms to check for signs of neurodivergence in children.
Page 1 of 2 - 25 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
